Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New technique may improve emergency IV placement in upper arm

NCT ID NCT01866501

Knowledge-focused Sponsor: Vidacare Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new method for finding the correct spot in the upper arm to place an emergency IV (intraosseous access). Fifteen healthy volunteers and trained medical staff participated. The goal was to see if the new technique improves accuracy and speed of insertion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Start date

May 2013

Finished

May 2013

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Device Operators: * Currently licensed/certified Emergency Medicine Technicians, paramedic, or nurse * Have had no formal training on use of the proximal humerus IO insertion site * Demonstrate proper use of the device and technique during training portion and obtain approval from the device trainer to participate Exclusion Criteria for Device Operators: None Inclusion Criteria Healthy Subjects: * Age 21 years or older * Have no amputation of the upper extremities * Able to lay flat on a table for up to 2 hours * Self-reported as healthy, as confirmed by the PI Exclusion Criteria Health Subjects: * Have an active infection in the body * Imprisoned * Pregnant * Cognitively impaired * Fracture in humerus, or significant trauma to the site * Excessive tissue and/or absence of adequate anatomical landmarks in humerus * Infection in target area * Humeral IO insertion in past 48 hours, prosthetic limb or joint or other significant orthopedic procedure in humerus * Current use of anti-coagulants * Current cardiac condition requiring pacemaker or anti-arrhythmic drugs * Prior adverse reaction to lidocaine * Volunteers with any of the following characteristics may be excluded from the infusion pathway evaluation involving administration of contrast dye at the discretion of the PI: * Prior adverse reaction to contrast dye * Allergy to any food or drug * History of impaired renal function * History of impaired hepatic function * History of cardiac disease * History of pheochromocytoma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intraosseous vascular access are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intraosseous vascular access Vascular access

Contacts and locations

Locations

  • Bulverde-Spring Branch EMS

    Spring Branch, Texas, 78070, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.